drugset

drugset / Trial / NCT03122340

Polyprenols (Ropren) in Acute Coronary Syndrome

NCT03122340 ↗

Phase 3 Completed 70 enrolled Tomsk National Research Medical Center of the Russian Academy of Sciences

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The aim of this study is to determine efficacy and safety of polyprenols (ROPREN) using in patients with acute coronary syndrome

Timeline

Start: 2015-11-01
Primary completion: 2017-12-31
Completion: 2018-02-28

Publications

Vyshlov EV, Tsoy EI, Sultanov VS, Trusov VB, Ryabov VV. Hypolipidemic and Hepatoprotective Effects of a Polyprenol-Containing Drug in Patients with Acute Coronary Syndrome. Bull Exp Biol Med. 2018 Jul;165(3):319-321. doi: 10.1007/s10517-018-4159-x. Epub 2018 Jul 12.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Ropren	Unknown	5 unknown	Oral

Indications